Historical return extremes for Moderna (MRNA) from 2018 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +3,852% | $12.26 | $484.47 | $39,516.31 | ||
| Max drawdownMore info about Max drawdown | -95.38% | $484.47 | $22.36 | $46.15 | ||
| Return since IPOMore info about Return since IPO | +168.33% | $18.60 | $49.91 | $2,683.33 |
- Max profitMore info about Max profit+3,852%$39,516.31
- Max drawdownMore info about Max drawdown-95.38%$46.15
- Return since IPOMore info about Return since IPO+168.33%$2,683.33
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Moderna (MRNA). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return